Dr. Lan Begins Integra-D Clinical Trial

Clinical testing of the FIRST implantable device combining cardiac contractility modulation with cardioversion/defibrillation capabilities is now underway in the MidSouth at Baptist Memorial Hospital in Memphis, TN with Dr. David Lan of Stern Cardiovascular Foundation.

About INTEGRA-D

The OPTIMIZER® Integra CCM-DTM System, also known as a “Cardiac Contractility Modulation - Defibrillator,” is an investigational device system that combines CCM® therapy and ICD therapy into one device. This research study is designed to determine if the OPTIMIZER® Integra CCM-DTM System can effectively defibrillate (shock the heart to restore a normal rhythm pattern) and treat episodes of ventricular tachycardia/ventricular fibrillation (VT/VF) should any occur.